“Nephron Sc Recalls Racepinephrine Inhaler Due to Short Fill Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34003-nephron-sc-recalls-racepinephrine-inhaler-due-to-short-fill-hazard. Based on FDA recall #D-0176-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0176-2023%22&limit=1).
Nephron Sc Inc voluntarily recalled S2 Racepinephrine Inhalation Solution due to a short fill hazard, according to the FDA on Jan. 13, 2023. The recall affects 925,920 vials distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: Nephron Sc
Product: S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch
NDC: 0487-5901-99
UPC: 3 04875 90199 9
Lot codes: 126461, 126431
Expiration date: 04/30/2023
The hazard
The product contains a short fill. The FDA classified the recall as Class II.
Context
GovInfoNow's records show Nephron Sc Inc has issued three other recalls since Aug. 10, 2022. On Feb. 23, 2023, the company recalled Sterile Water for Injection due to potential product carryover hazards from CGMP deviations. Other recent recalls of similar products include Nephron Albuterol Inhaler (March 17, 2026) and American Regent Epinephrine Injection (Aug. 11, 2026).
How to tell if you have this one
Check for vials labeled 'S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch'. The lot numbers 126461 or 126431 with expiration 04/30/2023 are affected.
Brand
Nephron Sc
Product
S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
Nationwide within the United States including Puerto Rico. Guatamala
Recall number
Product, codes & lots
Quantity
NDC
D-0175-2023
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4; Lot #: 126451 Exp. 04/30/2023
387,000 vials
—
D-0176-2023
S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9; Lot #: 126461, 126431 Exp. 04/30/2023
925,920 vials
0487-5901-99
Based on the official FDA remedy
What to do — step by step
Check Vial Details
Look for the lot numbers 126461 or 126431 and expiration date 04/30/2023 on the vial packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States including Puerto Rico. Guatamala” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0176-2023 (January 13, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0176-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.